Artiva Biotherapeutics (ARTV) Asset Utilization Ratio (2024)
Artiva Biotherapeutics (ARTV) posted quarterly Asset Utilization Ratio of 0.0 for Q4 2024, down 93.31% quarter-over-quarter from 0.02 in Q3 2024.
Powered by 
Analysis
Artiva Biotherapeutics (ARTV) Asset Utilization Ratio (2024) Analysis & Trends
Artiva Biotherapeutics (ARTV) has reported Asset Utilization Ratio for 1 consecutive years, with 0.0 the latest figure, recorded in Q4 2024.
- In Q4 2024, Asset Utilization Ratio changed N/A year-over-year to 0.0; the TTM figure through Dec 2024 stood at 0.0 (changed N/A YoY), while the FY2024 annual figure was 0.0, changed N/A from the prior year.
- Asset Utilization Ratio retreated to 0.0 in Q4 2024 per ARTV's latest filing, from 0.02 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.02 in Q3 2024 and bottomed at 0.0 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 0.20 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 0.69 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 0.90 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.13 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 0.54 |
| 10 | Artiva Biotherapeutics | 441.23 Mn | 441.23 Mn | - | - |